Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Micromegakaryocytes in Human Bone Marrow.

M Wiesneth, H Pflieger, B Kubanek

    Acta Haematologica
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Blood transfusion: influence of transfusion therapy on outcome.

    Current opinion in anaesthesiology·2006
    Same author

    Erythropoiesis and performance after two weeks of living high and training low in well trained triathletes.

    International journal of sports medicine·2002
    Same author

    Efficient retrovirus-mediated transduction of primitive human peripheral blood progenitor cells in stroma-free suspension culture.

    Gene therapy·2001
    Same author

    Practices and attitudes towards quality assurance, inspection and accreditation in blood collection establishments in the European community.

    Transfusion medicine (Oxford, England)·2000
    Same author

    The first case of HCV seroconversion after 3 years of HCV NAT screening in Baden-Württemberg.

    Transfusion·2000
    Same author

    Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation.

    Annals of hematology·2000
    Same journal

    Progression-free survival effect sizes in randomized controlled trials of targeted cancer therapies with positive outcomes.

    Acta haematologica·2026
    Same journal

    Dapagliflozin in Patients with homozygous β-Thalassemia and Albuminuria.

    Acta haematologica·2026
    Same journal

    Efficacy of second-generation FLT3 inhibitors in FLT3-mutated AML: A meta-analysis of randomized controlled trials.

    Acta haematologica·2026
    Same journal

    Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter study.

    Acta haematologica·2026
    Same journal

    Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection.

    Acta haematologica·2026
    Same journal

    Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies.

    Acta haematologica·2026
    See all related articles

    Micromegakaryocytes (MMK) are abnormal cells identified in bone marrow. High MMK percentages in leukemia patients may indicate pre-leukemic conditions or non-lymphatic leukemia.

    Area of Science:

    • Hematology
    • Oncology
    • Cell Biology

    Background:

    • Micromegakaryocytes (MMK) are small megakaryocytes with distinct morphological features.
    • Understanding MMK is crucial for diagnosing hematological malignancies.

    Purpose of the Study:

    • To define micromegakaryocytes (MMK) morphologically.
    • To investigate the frequency and significance of MMK in various hematological conditions.

    Main Methods:

    • Retrospective analysis of 7,156 bone marrow smears.
    • Morphological assessment of cell area, nucleus form, and cytoplasmic structure to identify MMK.

    Main Results:

    • Micromegakaryocytes (MMK) were most frequent in acute non-lymphatic leukemia, chronic myeloid leukemia, and pre-leukemia.

    Related Experiment Videos

  • Over 10% MMK in the megakaryocyte population suggests pre-leukemia or non-lymphatic leukemia.

    • Conclusions:

    • Morphological identification of MMK aids in diagnosing specific leukemias.
    • MMK presence may indicate pre-leukemic states or non-lymphatic leukemia, warranting further investigation into platelet function.